Advances in Experimental and Clinical Research of the Gouty Arthritis Treatment with Traditional Chinese Medicine
Open Access
- 20 October 2021
- journal article
- review article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-15
Abstract
Gouty arthritis (GA) is a multifactorial disease whose pathogenesis is utterly complex, and the current clinical treatment methods cannot wholly prevent GA development. Western medicine is the primary treatment strategy for gouty arthritis, but it owns an unfavorable prognosis. Therefore, the prevention and treatment of GA are essential. In China, traditional Chinese medicine (TCM) has been adopted for GA prevention and treatment for thousands of years. Gout patients are usually treated with TCM according to their different conditions, and long-term results can be achieved by improving their physical condition. And TCM has been proved to be an effective method to treat gout in modern China. Nevertheless, the pharmacological mechanism of TCM for gout is still unclear, which limits its spread. The theory of prevention and treatment of gout with TCM is more well acknowledged in China than in abroad. In this article, Chinese herbs and ancient formula for gout were summarized first. A total of more than 570 studies published from 2004 to June 2021 in PubMed, Medline, CNKI, VIP, Web of Science databases and Chinese Pharmacopoeia and traditional Chinese books were searched; the current status of TCM in the treatment of GA was summarized from the following aspects: articular chondrocyte apoptosis inhibition, antioxidative stress response, inflammatory cytokine levels regulation, uric acid excretion promotion, immune function regulation, uric acid reduction, and intestinal flora improvement in subjects with gout. The literature review concluded that TCM has a specific curative effect on the prevention and treatment of GA, particularly when combined with modern medical approaches. However, lacking a uniform definition of GA syndrome differentiation and the support of evidence-based medicine in clinical practice have provoked considerable concern in previous studies, which needs to be addressed in future research.Keywords
Funding Information
- National Administration of Traditional Chinese Medicine (201803190106)
This publication has 92 references indexed in Scilit:
- A study of Semen Strychni-induced renal injury and herb–herb interaction of Radix Glycyrrhizae extract and/or Rhizoma Ligustici extract on the comparative toxicokinetics of strychnine and brucine in ratsFood and Chemical Toxicology, 2014
- Epidemiology of GoutRheumatic Disease Clinics of North America, 2014
- Systems biology in drug discovery and developmentDrug Discovery Today, 2014
- Effects of Modified Simiao Decoction on IL‐1β and TNFα Secretion in Monocytic THP‐1 Cells with Monosodium Urate Crystals‐Induced InflammationEvidence-Based Complementary and Alternative Medicine, 2014
- Therapeutic Effect of Rhizoma Dioscoreae Nipponicae on Gouty Arthritis Based on the SDF‐1/CXCR 4 and p38 MAPK Pathway: An In Vivo and In Vitro StudyPhytotherapy Research, 2013
- Gout therapeutics: new drugs for an old diseaseThe Lancet, 2011
- Simiao pill ameliorates urate underexcretion and renal dysfunction in hyperuricemic miceJournal of Ethnopharmacology, 2010
- Treatment of 60 Cases of Gouty Arthritis with Modified Simiao TangJournal of Traditional Chinese Medicine, 2008
- Randomized and controlled clinical study of modified prescriptions of Simiao Pill (四妙丸) in the treatment of acute gouty arthritisChinese Journal of Integrative Medicine, 2008
- Hypouricemic Effects of Phenylpropanoid Glycosides Acteoside ofScrophularia ningpoensison Serum Uric Acid Levels in Potassium Oxonate-Pretreated MiceThe American Journal of Chinese Medicine, 2008